Changes in Medication Usage for T2DM: 1999-2010
the MPR take:
Based on data from the National Health and Nutrition Examination Survey, between 1999 and 2010, the use of metformin increased from 34.8% to 53.8% making it the most prevalent medication used in that time period by patients diagnosed with type 2 diabetes. The study, which involved 3094 type 2 diabetes patients, examined the use of medication indicated to reduce glucose, blood pressure, and lipids. Besides metformin, in 2007–2010, dipeptidyl peptidase-4 (DPP-4) inhibitors were used by 7.4% of patients; the first DPP-4 inhibitor, sitagliptin, was approved in 2006. Between 1999 and 2010, angiotensin receptor blocker use increased from 7.4% to 21.4%, beta-blocker use increased from 15.3% to 31.8%, and statin use doubled. By 2007–2010, 64.7% of patients were able to attain BP control, partly because of increased drug prescriptions, and 52.2% were taking a statin.